Healthcare Sector Review: Winning and Losing Stocks on Oct 17th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Anadys Pharmaceuticals (NASDAQ:ANDS): The shares closed at $3.67, up $2.63, or 252.88%, on the day. Its market capitalization is $209.84 million. About the company: Anadys Pharmaceuticals Inc. provides biopharmaceuticals. The Company discovers, develops, and commercializes small molecule, anti-infective medicines for the treatment of hepatitis C virus, or HCV, and bacterial infections. Anadys has several programs underway to deliver other HCV drug candidates.
  • Inhibitex, Inc. (NASDAQ:INHX): The shares closed at $3.63, up $0.43, or 13.44%, on the day. Its market capitalization is $283.81 million. About the company: Inhibitex Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel antibody-based products. The Company develops products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting.
  • Sequenom, Inc. (NASDAQ:SQNM): The shares closed at $5.56, up $0.24, or 4.51%, on the day. Its market capitalization is $551.43 million. About the company: Sequenom Inc. is a molecular diagnostic testing and genetics analysis company. The Company provides services, diagnostic testing, applications and genetic analysis products. Sequenom’s products translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research.
  • Cerus Corporation (NASDAQ:CERS): The shares closed at $2.49, up $0.09, or 3.75%, on the day. Its market capitalization is $118.77 million. About the company: Cerus Corporation develops systems designed to enhance the safety of blood transfusions. The Company’s systems inactivate pathogens in blood components and inactivate white blood cells, which are responsible for a variety of adverse transfusion reactions. Cerus’ platform technologies prevent viral, bacterial, and cellular replication.
  • Protalix BioTherapeutics (AMEX:PLX): The shares closed at $4.95, up $0.13, or 2.7%, on the day. Its market capitalization is $423.68 million. About the company: Protalix BioTherapeutics Inc. is a biotechnology company that has developed plant cell culture technology and a bioreactor system.

Losers (% price change)

  • Senomyx Inc. (NASDAQ:SNMX): The shares closed at $3.41, down $0.44, or 11.43%, on the day. Its market capitalization is $135.16 million. About the company: Senomyx, Inc. discovers new proprietary flavor and fragrance molecules for use in a wide range of consumer products. The company’s flavor and fragrance molecules are used by consumer products companies to improve the taste or smell of many products, including processed foods, beverages, perfumes and personal and home care products.
  • AVANIR Pharmaceuticals (NASDAQ:AVNR): The shares closed at $2.91, down $0.31, or 9.63%, on the day. Its market capitalization is $361.38 million. About the company: AVANIR Pharmaceuticals Inc. develops, acquires, and markets treatments for central nervous system disorders, inflammation, and infectious diseases.
  • Skilled Healthcare Group (NYSE:SKH): The shares closed at $3.98, down $0.4, or 9.13%, on the day. Its market capitalization is $151.32 million. About the company: Skilled Healthcare Group Inc. operates nursing and assisted-living homes in California, Texas, Kansas, and Nevada.
  • Synta Pharmaceuticals (NASDAQ:SNTA): The shares closed at $3.12, down $0.31, or 9.04%, on the day. Its market capitalization is $154.42 million. About the company: Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.
  • DepoMed, Inc. (NASDAQ:DEPO): The shares closed at $4.52, down $0.42, or 8.5%, on the day. Its market capitalization is $250.24 million. About the company: DepoMed, Inc. develops new and proprietary oral drug delivery technologies. The Company has developed a system designed to be retained in the stomach for an extended period of time while it delivers the incorporated drug or drugs. DepoMed has also developed a system designed to reduce gastrointestinal irritation.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>